A detailed history of Garden State Investment Advisory Services LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Garden State Investment Advisory Services LLC holds 3,070 shares of AZN stock, worth $237,832. This represents 0.08% of its overall portfolio holdings.

Number of Shares
3,070
Previous 3,097 0.87%
Holding current value
$237,832
Previous $210 Million 14.25%
% of portfolio
0.08%
Previous 0.08%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$66.81 - $80.83 $1,803 - $2,182
-27 Reduced 0.87%
3,070 $239 Million
Q1 2024

May 14, 2024

SELL
$61.03 - $69.57 $23,008 - $26,227
-377 Reduced 10.85%
3,097 $210 Million
Q3 2023

Nov 13, 2023

BUY
$64.85 - $71.7 $3,890 - $4,302
60 Added 1.76%
3,474 $235 Million
Q2 2023

Aug 14, 2023

BUY
$69.91 - $75.81 $238,672 - $258,815
3,414 New
3,414 $244 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $240B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Garden State Investment Advisory Services LLC Portfolio

Follow Garden State Investment Advisory Services LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Garden State Investment Advisory Services LLC, based on Form 13F filings with the SEC.

News

Stay updated on Garden State Investment Advisory Services LLC with notifications on news.